On February 12, 2020 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that the company plans to present at the following conferences (Press release, Iovance Biotherapeutics, FEB 12, 2020, View Source [SID1234554224]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Guggenheim Healthcare Talks | Oncology Day in New York, Feb. 13, 2020
Date/Time: Thursday, Feb. 13, at 2:00 p.m. EST
Webcast: a live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source
SVB Leerink 9th Annual Global Healthcare Conference in New York, Feb. 25-27, 2020
Date/Time: Wednesday, Feb. 26, at 3:00 p.m. EST
Webcast: a live and archived webcast of the presentation will be available in the Investors section of the Iovance website at View Source
6th Annual Immuno-Oncology 360° conference in New York, Feb. 26-28, 2020
Presentation Title: Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer
Date/Time: Thursday, Feb. 27, at 12:00 p.m. EST